Please login to the form below

Not currently logged in
Email:
Password:

Adocia names senior members of new US subsidiary

Simon Bruce and Stephen Daly join from Halozyme

edit-Adocia-Simon-BruceBiotech Adocia has named two senior members of its team that will be based at its new subsidiary in the US.

Simon Bruce (top pictured) has been named as chief medical officer, while Stephen Daly has been appointed as US commercial lead and will be in charge of the business development in the US in addition to US investor relations.

Bruce has over 15 years of experience in drug development and registrational drug trials. He joins from Halozyme Pharmaceuticals, where he held the position of executive medical director and worked on the ultra-rapid insulin programme.

Bruce has also held position at Amylin Pharmaceuticals, where he was in charge of Bydureon's phase III studies and safety analysis, a once weekly GLP-1 injectable formulation.

Daly has 24 years of experience in commercialisation and business development for pharma and biotech products across multiple therapeutic categories. He most recently served as VP of commercial at Halozyme, also on the ultra-rapid insulin programme.

Daly's experience in the diabetes field also includes several years at Amylin, where he worked on the marketing and brand leadership for Byetta and Symlin.

edit-Adocia-Stephen-Daly

Olivier Soula, R&D director and deputy general manager at Adocia, commented: “Their knowledge and experience in drug development, especially in the diabetes field, are unique from both medical and commercial perspective.

“They are indisputable assets to accelerate the development and commercialisation of our projects and to optimise our collaborative research in partnerships."

9th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics